Union Health Minister Mansukh Mandaviyaon informed the Lok Sabha on Friday that the COVID-19 virus mutated 223 times, resulting in reduced harmful effects over time.
He emphasised that COVID-19 will remain like influenza and current variants are not deadly.
During the Question Hour, Mandaviya stated, "When a virus mutates over 100 times, its harmful effects decrease. COVID-19 has mutated 223 times."
Comparing COVID-19 to influenza, he highlighted its persistent presence, noting that "Covid sub-variants are not that deadly."
Mandaviya emphasised the importance of global cooperation in healthcare, citing positive outcomes achieved during the pandemic through collaborative efforts.
India's robust pharmaceutical infrastructure was acknowledged, with Mandaviya stating that the country now produces 70% of the world's HIV/AIDS medicines.
He highlighted India's contribution to producing essential medicines recognized worldwide.
Speaker Om Birla echoed this sentiment, recounting his experience in Africa where Indian medicines were highly sought after and admired for their efficacy.
Highlighting the impact of healthcare policies, Mandaviya mentioned the Ayushman Bharat scheme, which provided free medical treatment up to Rs 5 lakh to 13 crore individuals, preventing them from falling below the poverty line due to medical expenses.
In contrast, during the previous government's tenure, 5.5 crore people slipped into poverty due to high medical costs.
Underlining the government's commitment to healthcare, Mandaviya noted an increase in healthcare expenditure to 1.35% of GDP, up from 1.13% in the previous government's tenure.
Follow us
